Sign up to see all 5.
Sign up to see all 5.
No insider has filed a notice of proposed sale (Form 144) for Neuphoria Therapeutics Inc in the last 12 months.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
LC
Lynx1 Capital Management LP
13D · 16.3%
|
875.3K | 16.18% | Unchanged | Q4 '25 | 0.4% | |
|
Shares held by quarter
Peak holding875.3K (Q1'26)
Change over 8 quarters+875.3K
Share of the company16.180%
Disclosed stake13D · 16.3%
|
||||||
|
AI
AdvisorShares Investments LLC
|
252.9K | 4.67% | +97.5K (+62.8%) | 2025 | 0.1% | |
|
Shares held by quarter
Peak holding252.9K (Q2'26)
Change over 8 quarters+252.9K
Share of the company4.670%
|
||||||
23 more super investors behind a free account
See every manager holding Neuphoria Therapeutics Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
AP
AdvisorShares Trust
|
$1.11M | 252.9K | 4.67% | 2.49% | June 30, 2026 |
|
VT
Vanguard Index Funds
|
$481K | 110.2K | 2.04% | 0.00% | June 30, 2026 |
5 more funds behind a free account
See every fund holding Neuphoria Therapeutics Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
CA
Christian Angermayer
5%+ holder
13D · 4.5%
|
72.6K | 1.34% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AI
Apeiron Investment Group Ltd.
5%+ holder
13D · 4.5%
|
72.6K | 1.34% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...